Zaki Mohamed has filed 5 insider transactions across 1 company since December 2024.
Most recent transaction: a grant/award of 285200 shares of ADC Therapeutics SA ($ADCT) on February 13, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | ADC Therapeutics SA | $ADCT | Zaki Mohamed | Chief Medical Officer | A | Common Shares | 285200 | $3.99 | 707,020.0000 | 136,446,534 | 67.61% | 0.21% |
| Feb. 13, 2026 | ADC Therapeutics SA | $ADCT | Zaki Mohamed | Chief Medical Officer | F | Common Shares | 24603 | $3.99 | 682,417.0000 | 136,446,534 | 3.48% | 0.02% |
| Dec. 6, 2025 | ADC Therapeutics SA | $ADCT | Zaki Mohamed | Chief Medical Officer | F | Common Shares | 41068 | $3.29 | 421,820.0000 | 136,446,534 | 8.87% | 0.03% |
| Feb. 13, 2025 | ADC Therapeutics SA | $ADCT | Zaki Mohamed | Chief Medical Officer | A | Common Shares | 230000 | $1.61 | 462,888.0000 | 97,159,966 | 98.76% | 0.24% |
| Dec. 6, 2024 | ADC Therapeutics SA | $ADCT | Zaki Mohamed | Chief Medical Officer | F | Common Shares | 37112 | $3.13 | 232,888.0000 | 104,824,877 | 13.75% | 0.04% |